• Clipperton acted as sole financial advisor to Hublo, a leading provider of digital HR solutions for the healthcare sector, on its investment by Five Arrows, the investment fund of Rothschild & Co. 
  • Five Arrows will provide Hublo with long-term strategic and operational support, helping the company accelerate its growth – both organically and through acquisitions – and amplify its impact in France and internationally.
  • This transaction marks the 16th tech buy-out deal of Clipperton over the last 12 months, with recent transactions such as Didomi’s LBO with Marlin Equity Partners or FTV’s investment in N2F. 

Our client

  • Since its founding in 2016, Hublo has been on a mission to transform the daily lives of healthcare professionals by modernising the way human resources are managed. Its innovative software suite enables healthcare organisations to recruit, manage, and retain their teams more effectively, allowing staff to focus on what matters most – patient care. Today, Hublo’s solutions are used by over 5,000 healthcare and social care institutions and more than one million caregivers across France.
  • In a healthcare software market that remains highly fragmented, Hublo is positioning itself as the leading provider of a unified digital platform dedicated to workforce management. To achieve this ambition, the company is pursuing a strategy focused on continuous innovation, the expansion of its product offering, and the development of strategic partnerships, most recently demonstrated through the acquisitions of Permuteo and Staffea in April 2025.

Deal Rationale

  • The investment from Five Arrows will support Hublo, alongside its founding and leadership team, in accelerating its growth journey – both organically and through acquisitions – in France and internationally. With deep experience in scaling healthcare technology platforms, Five Arrows will bring long-term strategic and operational support to the company.
  • Revaia, Hublo’s anchor shareholder since 2021, will sell its stake held through the Revaia Growth I fund as part of the transaction. As a testament to its continued confidence in Hublo and its leadership team, Revaia is considering a significant reinvestment alongside Five Arrows, reaffirming its commitment to supporting the company in the next phase of its journey.
  • Antoine Loron, co-founder and co-CEO of Hublo, commented: “The entry of Five Arrows marks a significant step in our growth. With their support, we are well positioned to deliver on our vision – both in France and abroad – to service the healthcare system. A new chapter begins.”

Clipperton’s extensive track record with LBO deals for European tech leaders

This transaction marks the 16th tech buy-out deal of Clipperton over the last 12 months, with recent transactions such as Didomi’s LBO with Marlin Equity Partners or FTV’s investment in N2F. 

The exit landscape for VC-backed startups has undergone a substantial transformation over the past decade, notably thanks to the emerging trend of what we like to call “VC-to-PE deals”. While exits to PE funds made up just 8% of total exits for VC-funded companies between 2006 and 2010, that figure has surged to a whopping 24% for the years 2021 to 2024. Read more about the VC-to-PE landscape in our recently published research paper. 

Clipperton’s track record in the HR Tech space 

This transaction is testimony to Clipperton’s know-how in advising HR tech pioneers, with credentials such as Mistertemp’s LBO with Andera Partners, Welcome to the Jungle’s €50m Series C, and Foederis Group’s sale to Septeo.  

Deal Team: 

Debt Advisory:

About Clipperton

Clipperton is a leading pan-European investment bank dedicated to technology and growth companies, with offices in Paris, Berlin, Munich, London, and Amsterdam, as well as partnerships in the USA, China, Italy, and Spain. We provide strategic and financial advisory to entrepreneurs, corporates, and top-tier investors in Europe who are looking to execute strategic M&A, private equity, private placements, and debt financing transactions. Founded in 2003, we have completed over 500 deals with fast-growing technology start-ups, blue-chip corporates, and renowned financial investors.